Neil Minkoff, MD: One of the things we had already touched on was patients ending up in the hospital in the emergency department [ED], and the overall clinical and economic ramifications of the ...

Neil Minkoff, MD: That’s such an important aspect in terms of balancing what’s right for each patient. I’m going to pull Dr Drummond in here to comment on that further. We started touching on the idea ...

If you have breathing problems caused by certain lung conditions, your doctor may prescribe Spiriva for you. Spiriva is a prescription drug that comes in two forms. The form your doctor prescribes ...

person holding blue asthma inhaler Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 ...

Please provide your email address to receive an email when new articles are posted on . A Montreal Cognitive Assessment score of 16 or less, which implies dementia, predicted errors in using inhalers.

Chronic obstructive pulmonary disease (COPD) is a chronic lung condition characterized by loss of lung elasticity, which leads to dysfunctional gaseous exchange. COPD is the third leading cause of ...

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

Bulletin: ...WINTER STORM WATCH REMAINS IN EFFECT FROM THIS AFTERNOON THROUGH FRIDAY AFTERNOON... * WHAT...Heavy snow possible. Total accumulations over 6 inches ...

Drugs already used by millions to lower cholesterol might someday have a new role: Relieving asthma and COPD. That's the hope of a new line of research underway at the University of California, Davis.

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of Inhaler Tales – a national ...